<SEC-DOCUMENT>0001628280-24-046265.txt : 20241107
<SEC-HEADER>0001628280-24-046265.hdr.sgml : 20241107
<ACCEPTANCE-DATETIME>20241107161116
ACCESSION NUMBER:		0001628280-24-046265
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20241107
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241107
DATE AS OF CHANGE:		20241107

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cibus, Inc.
		CENTRAL INDEX KEY:			0001705843
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE CHEMICALS [2870]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				271967997
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38161
		FILM NUMBER:		241435770

	BUSINESS ADDRESS:	
		STREET 1:		6455 NANCY RIDGE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		(858) 450-0008

	MAIL ADDRESS:	
		STREET 1:		6455 NANCY RIDGE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Calyxt, Inc.
		DATE OF NAME CHANGE:	20170504
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cbus-20241107.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:6f2d5f58-9b0f-4008-a57c-29f803b86dc3,g:e089b08c-f7f8-44a9-a150-acc3899c9e1d,d:3fd09091a7a24f4a91b3c155deae6557-->
<html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cbus-20241107</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0001705843</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cbus-20241107.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001705843</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-07</xbrli:startDate><xbrli:endDate>2024-11-07</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i3fd09091a7a24f4a91b3c155deae6557_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report: (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">November 7, 2024</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Cibus, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-38161</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">27-1967997</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction<br/>of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:48.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">6455 Nancy Ridge Drive</ix:nonNumeric></span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-9">CA</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">92121</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(Zip Code)</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">858</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">450-0008</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">______________________</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:3.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.052%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.264%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Trading<br/>Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name of exchange<br/>on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Class A Common Stock, $0.0001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">CBUS</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">The NASDAQ Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter). Emerging growth company  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">o</ix:nonNumeric></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i3fd09091a7a24f4a91b3c155deae6557_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02. &#160;&#160;&#160;&#160;Results of Operations and Financial Condition.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 7, 2024, Cibus, Inc. (the &#8220;Company&#8221;) announced its financial results for the three months ended September 30, 2024, and provided a year-to-date business update. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. <br/><br/>The information in Item 2.02 of this Form 8-K (including Exhibit 99.1) shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (&#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing, regardless of any general incorporation language in any such filing, unless the Company expressly sets forth in such filing that such information is to be considered &#8220;filed&#8221; or incorporated by reference therein.<br/></span></div><div id="i3fd09091a7a24f4a91b3c155deae6557_10"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d) Exhibits</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:89.355%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="cbus-20240930xpr.htm">Press Release, dated November 7, 2024</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i3fd09091a7a24f4a91b3c155deae6557_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, Cibus, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dated: November 7, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CIBUS, INC.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Rory Riggs</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rory Riggs</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer and Chairman</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>cbus-20240930xpr.htm
<DESCRIPTION>EX-99
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i1940c57ea5bc40ad82284263a0d4af9a_1"></div><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2024</font></div><div style="text-align:center"><font><br></font></div><div id="i1940c57ea5bc40ad82284263a0d4af9a_4"></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Announced a strategic realignment to advance commercial opportunities, focusing resources on advancement of weed management platform (HT1 and HT3) for Rice, Pod Shatter Reduction in Canola, Sclerotinia resistance for Canola and Soybean, and on Soybean platform development</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Great progress in Rice as we execute on our agreements with four major seed company customers in the United States and Latin America, with germplasm received from all customers&#59; completed successful field trials with HT3 in customer germplasm, as well as completed what the Company believes to be the first field trials for stacked gene-edited herbicide tolerance traits </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Also in Rice, signed an Agreement with RTDC Corporation Limited and Albaugh LLC to continue a collaboration expected to bring Cibus' HT3 trait (Clethodim-tolerant) to United States rice seed customers utilizing Albaugh's herbicide registration and crop protection expertise</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">In Canola, completed initial UK field trial for Pod Shatter Reduction in Winter Oilseed Rape&#59; continued progress in Sclerotinia resistance with a successfully completed field trial for second mode of action&#59; and awaiting results from greenhouse testing for third mode of action for Sclerotinia resistance&#59; received positive greenhouse results for HT2 </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Soybean platform, which will be a key inflection point for Cibus, remains on track to be operational by year end 2024</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Initiated actions to achieve $10 million in cost savings on an annualized run-rate basis consistent with strategic alignment and continuing transformation from an R&#38;D-focused company to the first commercial stage gene editing company in agriculture, with expected reduction of monthly cash usage by approximately 20%</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:115%"><br></font></div><div id="i1940c57ea5bc40ad82284263a0d4af9a_7"></div><div style="text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SAN DIEGO, November</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> 7, 2024 </font><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8211; Cibus, Inc. (Nasdaq&#58; CBUS) (the &#34;Company&#34;), </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds</font><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, today announced its financial results for the third quarter</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> ended</font><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> September&#160;30, 2024, and provided a year-to-date business update for 2024. Management will host a conference call and webcast today at 4&#58;30 p.m. ET.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Management Commentary</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#34;This has been a transformative first nine months for Cibus, and as we end this quarter, I'm pleased to report that all of our operational crop platforms now have field studies or greenhouse data with multiple traits and customer relationships, which we believe validates our technology and commercial approach,&#34; stated Rory Riggs, Co-Founder, Chairman, and CEO of Cibus. &#34;We are actively working with our customers to advance germplasm with our traits toward commercialization. In light of these relationships and their stage of development, we </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">have recently provided more detailed timelines around anticipated launches which are expected to lead to royalty revenues and allow our stakeholders to better benchmark our commercial progress and prospects.&#34; </font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Mr. Riggs continued, &#34;We are also continuing to take proactive steps to focus on advancing our highest priority objectives. Our recently announced strategic realignment focuses the allocation of our capital resources toward our commercial efforts through advancement of our weed management traits for Rice, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Sclerotinia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> resistance trait for Canola and Soybean, and the continuing development of our Soybean platform, while enabling continued progress on our Pod Shatter Reduction trait and our third weed management trait HT2 utilizing a more streamlined use of resources.&#34;<br><br>&#34;Our Rice platform exemplifies the progress we've made with our HT1 and HT3 herbicide traits gaining substantial momentum this year and which we anticipate will be utilized eventually as stacked traits in an integrated weed management platform. We have agreements with four major Rice seed company customers in North and Latin America and we've received germplasm from each of these customers. All of this progress is made possible by our Trait Machine process, a paradigm shift in breeding complex traits, as we can now complete edits in a customer's elite germplasm and return it within as few as 12 months. This breakthrough in speed and predictability allows us to work seamlessly with seed companies, augmenting their breeding operations with our capabilities in complex gene-editing.&#34;</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#34;We've also made significant strides in our Advanced Traits this year, particularly with our work in productivity traits. We have received successful field trial results for a second mode of action for </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Sclerotinia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> resistance in Canola, and greenhouse testing is underway for the third mode of action. With our </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Sclerotinia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> resistance trait being a multi-crop trait, the incredible progress we are making in Canola is foundational to the development of this trait for our Soybean platform, once operational. Additionally, we have encouraging greenhouse data for our HT2 edits in Canola as we head into anticipated field trials in 2025. These aren't just technological achievements &#8211; they represent products advancing toward commercialization with real royalty potential.&#34;</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Mr. Riggs concluded, &#34;As we complete our transformation from an R&#38;D-focused company to the first commercial-stage gene editing company in agriculture, we're setting the stage for a new industry of gene-edited traits. Our progress positions Cibus at the forefront of agricultural innovation. The fact that we now have validating data for multiple traits across our operational crop platforms, with customers moving forward toward commercialization, proves that our technology is working. But we are not just developing traits, we are creating commercial products alongside our seed company customers with the potential to generate meaningful revenue while pioneering a more sustainable and productive future for global agriculture by addressing critical challenges such as disease resistance and herbicide tolerance across multiple major crops.&#34;</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commercial Progress</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Progress of Cibus' Developed Traits</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Weed Management (HT1 and HT3) in Rice</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Including Cibus' second quarter agreement with FEDEARROZ, Cibus has agreements with four customers, including major Rice seed companies in North and Latin America to have Cibus' HT traits placed in their elite germplasm as they move toward potential commercialization.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Received germplasm from all four Rice customers.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Completed a successful field trial in the US with a customer's germplasm.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Cibus, RTDC Corporation Limited, and Albaugh LLC entered into an amendment to certain existing agreements to continue a collaboration that brings Cibus' Clethodim-tolerant Rice (HT3 trait) to US rice seed customers utilizing Albaugh's herbicide registration and crop protection expertise and establishes related financial obligations among the parties, including with respect to the allocation of trait fees and royalties received by Cibus.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Received initial field trial results for stacked gene edited herbicide tolerance traits in Rice&#59; we believe this is the first trial use of stacked gene edited herbicide tolerance traits in Rice to improve weed management.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR)</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Completed successful initial PSR field trials for WOSR in the UK for multiple customers, an important milestone in furthering Cibus' commercialization efforts for WOSR in Europe. </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Planted next round of UK field trials in the third quarter and expect to receive data in 2025 harvest season.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Progress of Cibus' Advanced Traits and Sustainable Ingredients</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Sclerotinia Resistance</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Received field trial results for second mode of action in Canola.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Canola plants containing third mode of action are currently under evaluation in a controlled greenhouse environment with results expected later this year and field trials planned for 2025.</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Herbicide Tolerance (HT2)</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Received positive greenhouse data for HT2 edits in Canola&#59; now moving to the field with initial field trial data anticipated in 2025.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Sustainable Ingredients</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Continued progress toward current partner-funded project.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Progress within Crop Platforms</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">Soybean Platform</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Expect Soybean platform to be operational by year end 2024, allowing access to this large market of approximately 125 million accessible acres.</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Corporate and Industry Progress</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Expansion of IP coverage for plant gene editing and traits</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Through the first nine months of 2024, Cibus received additional patents across 10 plant gene editing and trait families, further strengthening the Company's IP portfolio including in its Pod Shatter Reduction and Herbicide Tolerance trait families. </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">The IP expansion covers gene editing, productivity traits and quality traits that strengthen Cibus' patent coverage in geographies including, but not limited to, Europe, Asia, Latin America, and North America.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Canada added to growing list of countries regulating Cibus' gene editing technologies similar to conventional breeding in feed</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">In May 2024, the Canadian Food Inspection Agency (CFIA), Animal Feed Division published updated guidelines outlining the CFIA's approach to regulating feed products&#47;ingredients from gene editing like those developed through conventional breeding. </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Other global markets&#58; The movement of other countries approving gene editing as similar to conventional breeding techniques continues to expand as momentum builds globally.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13.8pt">Initiated actions in support of advancing streamlined commercial strategy</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Includes actions to achieve $10 million in cost savings on an annualized run-rate basis.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">When these and other initiatives are fully implemented by early 2025, the Company expects them to translate to a reduction in monthly cash use by approximately 20%.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">The Company anticipates incurring a one-time charge associated with severance expenses in the fourth quarter of fiscal 2024.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13.8pt">In the third quarter, raised approximately $12.1 million of net proceeds, inclusive of proceeds from a partial exercise of underwriters' option, in an SEC-registered underwritten offering.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Cibus intends to use the net proceeds from this offering to fund further development of new, and improvement of existing, seed traits, Trait Machine operations, and for working capital and general corporate purposes.</font></div><div><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1940c57ea5bc40ad82284263a0d4af9a_13"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Expected Milestones</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cibus intends to report ordinary course development progress and achievements in connection with its quarterly reporting process. Cibus presents below the most significant development and commercial milestone targets for its priority programs for the remainder of 2024 and 2025&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Soybean Platform&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:13.9pt">Expect Soybean single-cell regeneration platform to be operational and complete initial editing by end of 2024.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Sclerotinia&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Canola greenhouse testing results for third mode of action expected in 2024, with field trials planned for 2025.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Expect results from greenhouse testing for fourth mode of action in Canola in first quarter 2025.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">HT2 in Canola&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Expect initial field trial data in 2025.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;padding-left:12.03pt">Partner-Funded Sustainable Ingredient Development&#58;</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Continue progress on partner-funded project to develop sustainable low carbon ingredients or materials for the consumer packaged goods industry that do not negatively impact the environment during production, use, or disposal.</font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:13.9pt">Expect to receive initial amounts related to previously announced increase in funding for this sustainable ingredients effort for 2024 and 2025.</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div id="i1940c57ea5bc40ad82284263a0d4af9a_16"></div><div><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Third Quarter 2024 Financial Results</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As a reminder, the business combination of Cibus, Inc. (formerly known as Calyxt, Inc. prior to the business combination) (Legacy Calyxt) and Cibus Global, LLC was completed on May 31, 2023, thus the first five months of the 2023 information provided in the Financial Results, Condensed Consolidated Statements of Operations, and Condensed Consolidated Statements of Cash Flows is that of Legacy Calyxt only. Year-over-year comparisons are not comparable as 2024 includes the combined company whereas 2023 only includes Legacy Calyxt for the first five months.<br> <br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:12.03pt">Cash position&#58;&#160;Cash and cash equivalents as of September&#160;30, 2024, was $28.8 million. Taking into account the impact of implemented cost saving initiatives and without giving effect to potential financing transactions that Cibus is pursuing, Cibus expects that existing cash and cash equivalents will fund planned operating expenses and capital expenditure requirements</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> into late in the first quarter of 2025. Cibus' Board continues to evaluate a full range of strategic alternatives to maximize shareholder value.</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.53pt">Research and development (R&#38;D) Expense&#58;&#160;R&#38;D expense was $13.0 million for the quarter ended September&#160;30, 2024, compared to $17.5 million in the year-ago period. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The decrease of $4.5</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> million is primarily due to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">lower non-cash stock compensation expense and the strategic realignment and reduction in force announced during the fourth quarter of 2023 which included decreases in personnel costs and supplies.</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">Selling, general, and administrative (SG&#38;A) expense&#58; SG&#38;A expense was $7.7 million for the quarter ended September&#160;30, 2024, compared to $8.8 million in the year-ago period. The decrease</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of $1.1 million is primarily due to lower non-cash stock compensation expense.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.53pt">Goodwill impairment&#58; Goodwill impairment was </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$181.4</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> million for the quarter ended September&#160;30, 2024. T</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">he non-cash expense is due to the impairment of goodwill acquired in the merger with Cibus Global, LLC completed on May 31, 2023. Considering the decline in the Company's stock price since its last annual assessment of Goodwill, the Company performed a quantitative analysis in the third quarter of 2024 and concluded that its goodwill was impaired.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">Royalty liability interest expense - related parties&#58; Royalty liability interest expense - related parties was </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$8.9</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> million for the quarter ended September&#160;30, 2024, compared to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">$8.1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> million in the year-ago period</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The increase is </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">due to increase in the royalty liability balance</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.<br><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">Non-operating income (expenses), net&#58; Non-operating income (expenses), net was income of $7.7 million for the quarter ended September&#160;30, 2024, compared to expense of $0.9 million in the year-ago period. The increase in income of $8.6 million is driven by the fair value adjustment of the liability classified common warrants. <br><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.53pt">Net loss&#58;&#160;Net loss was $201.5 million for the quarter ended September&#160;30, 2024, compared to $34.5 million in the year-ago period. The increase of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$166.9</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> million in net loss was driven by the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">$181.4</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> million non-cash goodwill impairment. Without the goodwill impairment, net loss decreased by $14.5 million primarily related to the items described above.<br><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:12.03pt">Net loss per share of Class A common stock&#58; Net loss per share of Class A common stock was $7.63 for the quarter ended September&#160;30, 2024, compared to $1.59 in the year-ago period. The increase of $6.04 in net loss per share of Class A common stock is primarily driven by the non-cash goodwill impairment which accounted for approximately $7.53 in net loss per share of Class A common stock. This is partially offset by the decreases in net loss described above and a year-over-year increase in weighted average shares outstanding.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><br><br></font></div><div id="i1940c57ea5bc40ad82284263a0d4af9a_22"></div><div style="text-align:justify"><font style="background-color:#fefefe;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Conference Call and Webcast Information<br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cibus will host a live webcast, Thursday, November 7, 2024, at 4&#58;30 p.m. Eastern Time to discuss its third quarter 2024 financial results and provide a year-to-date business update. The conference call can be accessed live over the phone by dialing (877) 300-8521 or for international callers by dialing (412) 317-6026. A replay of the call will be available through November 21, 2024, by dialing (844) 512-2921 or for international callers by dialing (412) 317-6671&#59; the passcode is 10192371.<br><br>A live audio webcast of the call will be available under &#34;Events &#38; Presentations&#34; in the Investor section of the Company's website, investor.cibus.com. An archived webcast will be available on the Company's website for 90 days after the event.<br><br></font></div><div id="i1940c57ea5bc40ad82284263a0d4af9a_25"></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About Cibus</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop and license traits to seed companies in exchange for royalties on seed sales. Cibus' long-term focus is productivity traits for farmers for the major global row crops with large acreage such as canola, corn, rice, soybean, and wheat. Cibus is a technology leader in high-throughput gene editing technology that is expected to enable it to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus has developed a current pipeline of five productivity traits including important traits for weed management in Rice, Pod Shatter Reduction, and </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Sclerotinia</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (disease) resistance, which are its near-term focus. </font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">About the Cibus Trait Machine</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">TM </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">process and Rapid Trait Development System</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">TM</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A key element of Cibus' technology breakthrough is its high-throughput breeding process (referred to as the Trait Machine&#8482; process). The Trait Machine process is a crop specific application of Cibus' patented Rapid Trait Development System&#8482; (</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">RTDS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#174;). The proprietary technologies in RTDS integrate crop specific cell biology platforms with a series of gene editing technologies to enable a system of end-to-end crop specific precision breeding. It is the core technology platform for Cibus' Trait Machine process&#58; the first standardized end-to-end semi-automated crop specific gene editing system that directly edits a seed company's elite germplasm. Each Trait Machine process requires a crop specific cell biology platform that enables Cibus to edit a single cell from a customer's elite germplasm and grow that edited cell into a plant with the Cibus edits. </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Cibus believes that RTDS and the Trait Machine process represent the technological breakthrough in plant breeding that is the ultimate promise of plant gene editing&#58; &#34;high- throughput gene editing systems operating as an extension of seed company breeding programs.&#34; In 2024, the Trait Machine process was cited by Fast Company Magazine as one of the most innovative products in 2024. </font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%"><br><br></font></div><div id="i1940c57ea5bc40ad82284263a0d4af9a_28"></div><div style="margin-bottom:0.05pt;margin-top:0.05pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Forward Looking Statements</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This press release contains &#34;forward-looking statements&#34; within the meaning of applicable securities laws, including The Private Securities Litigation Reform Act of 1995. All statements, other than statements of present or historical fact included herein, including statements regarding Cibus' operational and financial performance, Cibus' liquidity and capital resources, the implementation and execution of cost savings initiatives, Cibus' strategy, future operations, prospects, and plans, including the anticipated receipt of commercial revenues and additional funding, are forward-looking statements. Cibus' assessment of the period of time through which its financial resources will be adequate to support its operations is a forward-looking statement. Because this involves such risks and uncertainties, the Company could use its available capital resources sooner than it currently expects. Forward-looking statements may be identified by words such as &#34;anticipate,&#34; &#34;believe,&#34; &#34;intend,&#34; &#34;expect,&#34; &#34;plan,&#34; &#34;scheduled,&#34; &#34;could,&#34; &#34;would&#34; and &#34;will,&#34; or the negative of these and similar expressions.</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">These forward-looking statements are based on the current expectations and assumptions of Cibus' management about future events, which are based on currently available information. These forward-looking statements are subject to numerous risks and uncertainties, many of which are difficult to predict and beyond the control of Cibus. Cibus' actual results, level of activity, performance, or achievements could be materially different than those expressed, implied, or anticipated by forward-looking statements due to a variety of factors, including, but not limited to&#58; Cibus' need for additional near-term funding to finance its activities and challenges in obtaining additional capital on acceptable terms, or at all&#59; changes in expected or existing competition&#59; challenges to Cibus' intellectual property protection and unexpected costs associated with defending intellectual property rights&#59; increased or unanticipated time and resources required for Cibus' platform or trait product development efforts&#59; Cibus' reliance on third parties in connection with its development activities&#59; challenges associated with Cibus' ability to effectively license its productivity traits and sustainable ingredient products&#59; the risk that farmers do not recognize the value in germplasm containing Cibus' traits or that farmers and processors fail to work effectively with crops containing Cibus' traits&#59; delays or disruptions in the Company's platform or trait product development efforts, particularly with respect to its non-Rice and non-disease projects in light of the Company's realigned strategic priorities&#59; challenges that arise in respect of Cibus' production of high-quality plants and seeds cost effectively on a large scale&#59; Cibus' dependence on distributions from Cibus Global, LLC to pay taxes and cover its corporate and overhead expenses&#59; regulatory developments that disfavor or impose significant burdens on gene-editing processes or products&#59; delays and uncertainties </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">regarding regulatory developments in the European Union&#59; Cibus' ability to achieve commercial success&#59; commodity prices and other market risks facing the agricultural sector&#59; technological developments that could render Cibus' technologies obsolete&#59; changes in macroeconomic and market conditions, including inflation, supply chain constraints, and rising interest rates&#59; dislocations in the capital markets and challenges in accessing liquidity and the impact of such liquidity challenges on Cibus' ability to execute on its business plan&#59; the outcome of any litigation related to the Merger Transactions&#59; the Company's assessment of the period of time through which its financial resources will be adequate to support operations&#59; and other important factors discussed in the &#34;Risk Factors&#34; section of Cibus' Annual Report on Form 10-K which was filed with the Securities and Exchange Commission (the &#34;SEC&#34;) on March 21</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, 2024</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Should one or more of these risks or uncertainties occur, or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements.</font></div><div style="margin-bottom:0.08pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In addition, the forward-looking statements included in this press release represent Cibus' views as of the date hereof. Cibus specifically disclaims any obligation to update such forward-looking statements in the future, except as required under applicable law. These forward-looking statements should not be relied upon as representing Cibus' views as of any date subsequent to the date hereof.<br><br></font></div><div id="i1940c57ea5bc40ad82284263a0d4af9a_31"></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:125%">CIBUS CONTACTS&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INVESTOR RELATIONS</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>Karen Troeber<br>ktroeber&#64;cibus.com<br>858-450-2636</font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Jeff Sonnek &#8211; ICR </font></div><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:125%">jeff.sonnek&#64;icrinc.com<br><br></font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:125%">MEDIA RELATIONS</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Colin Sanford<br>colin&#64;bioscribe.com<br>203-918-4347</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1940c57ea5bc40ad82284263a0d4af9a_34"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CIBUS, INC. </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited and in Thousands, Except Par Value and Share Amounts) </font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.927%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">September 30, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">December 31, 2023</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Assets</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Current assets&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Cash and cash equivalents</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">28,805</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">32,699&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Accounts receivable</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,190</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">530&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,578</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">1,991&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total current assets</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">31,573</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">35,220&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Property, plant, and equipment, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">12,910</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">15,775&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Operating lease right-of-use assets</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">34,432</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">21,685&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Intangible assets, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">34,036</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">35,411&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Goodwill</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">253,466</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">434,898&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other non-current assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,457</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">1,422&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total assets</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">367,874</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">544,411&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Liabilities, redeemable noncontrolling interest, and stockholders&#8217; equity</font></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Current liabilities&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accounts payable</font></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">7,023</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">6,127&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accrued expenses</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">3,323</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">1,747&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accrued compensation</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">3,229</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">3,858&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Deferred revenue</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,082</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">1,210&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Current portion of notes payable</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">337</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">833&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Current portion of financing lease obligations</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">110</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">187&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Current portion of operating lease obligations</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">4,150</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">5,927&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Class A common stock warrants</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">2,661</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">1,418&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other current liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">16&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Total current liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">21,918</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">21,323&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Notes payable, net of current portion</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">291</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">536&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Financing lease obligations, net of current portion</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">113&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Operating lease obligations, net of current portion</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">31,851</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">17,025&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Royalty liability - related parties</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">191,205</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">165,252&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Other non-current liabilities</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">1,728</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">1,868&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total liabilities</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">246,993</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">206,117&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Redeemable noncontrolling interest</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">12,741</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">44,824&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.927%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">September 30, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:125%">December 31, 2023</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Stockholders&#8217; equity&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Class A common stock, $0.0001 par value&#59; 210,000,000 shares authorized&#59; 26,866,904 shares issued and 26,429,630 shares outstanding as of September 30, 2024&#59; 21,240,379 shares issued and 20,567,656 shares outstanding as of December 31, 2023</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">8&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Class B common stock, $0.0001 par value&#59; 90,000,000 shares authorized&#59; 3,112,516 shares issued and outstanding as of September 30, 2024, and 3,142,636 shares issues and outstanding as of December 31, 2023</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Additional paid-in capital</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">818,210</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">775,017&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Class A common stock in treasury, at cost&#59; 45,177 shares as of September 30, 2024, and 32,663 shares as of December 31, 2023</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(1,999)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(1,785)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">Accumulated deficit</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(708,064)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">(479,778)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Accumulated other comprehensive income (loss)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">(15)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">8&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">Total stockholders&#8217; equity</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">108,140</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">293,470&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:125%">Total liabilities, redeemable noncontrolling interest, and stockholders&#8217; equity</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:114%">367,874</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">544,411&#160;</font></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1940c57ea5bc40ad82284263a0d4af9a_37"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CIBUS, INC. </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited and in Thousands, Except Share and Per Share Amounts) </font></div><div style="margin-bottom:0.08pt"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.280%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:114%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Three Months Ended September 30,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Nine Months Ended September 30,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2024</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2023</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2024</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2023</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Revenue&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 29pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Revenue</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,667</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">475&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">3,050</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">714&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Total revenue</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,667</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">475&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">3,050</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">714&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Research and development</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">12,990</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">17,521&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">37,996</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">28,159&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling, general, and administrative</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">7,682</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">8,751&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">23,994</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">22,126&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Goodwill impairment</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">181,432</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">181,432</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Total operating expenses</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">202,104</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">26,272&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">243,422</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">50,285&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Loss from operations</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(200,437)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(25,797)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(240,372)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(49,571)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Royalty liability interest expense - related parties</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(8,875)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(8,136)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(25,953)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(10,753)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other interest income, net</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">160</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">281&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">522</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">359&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Non-operating income (expense), net</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">7,706</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(876)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">8,917</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(466)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Loss before income taxes</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(201,446)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(34,528)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(256,886)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(60,431)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income tax expense</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(13)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(23)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net loss</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(201,459)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(34,528)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(256,909)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(60,431)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net loss attributable to redeemable noncontrolling interest</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(21,491)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(8,099)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(28,623)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(9,918)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net loss attributable to Cibus, Inc.</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(179,968)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(26,429)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(228,286)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(50,513)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Basic and diluted net loss per share of Class A common stock</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(7.63)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1.59)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(10.33)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(6.33)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted average shares of Class A common stock outstanding &#8211; basic and diluted</font></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">23,586,746</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">16,641,127</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">22,105,979</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7,979,132</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i1940c57ea5bc40ad82284263a0d4af9a_40"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:12pt;text-align:center"><img alt="cibus_logoxrgba.jpg" src="cibus_logoxrgba.jpg" style="height:72px;margin-bottom:5pt;vertical-align:text-bottom;width:294px"></div></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CIBUS, INC. </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS </font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited and in Thousands) </font></div><div style="margin-bottom:0.08pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.08pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:75.304%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.456%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.656%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:114%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:125%">Nine Months Ended September 30,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2024</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:114%">2023</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Operating activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Net loss</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(256,909)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(60,431)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Adjustments to reconcile net loss to net cash used by operating activities&#58;</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Royalty liability interest expense - related parties</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">25,953</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10,753&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Goodwill impairment</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">181,432</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Depreciation and amortization</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">5,211</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2,875&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Stock-based compensation</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">8,030</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">11,670&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Change in fair value of liability classified Class A common stock warrants</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(8,908)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,221&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(16)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">17&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Changes in operating assets and liabilities, net of acquisitions&#58;</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts receivable</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(660)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,674&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Due to&#47;from related parties</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(95)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">412</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,111&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts payable</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">838</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(61)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accrued expenses</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,304</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,357&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accrued compensation</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(628)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">738&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred revenue</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(133)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">340&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Right-of-use assets and lease obligations, net</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">302</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(28)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other assets and liabilities, net</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(276)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(334)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net cash used by operating activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(44,048)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(29,193)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Investing activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cash acquired from merger with Cibus Global, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">59,381&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Purchases of property, plant, and equipment</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(752)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3,872)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net cash (used by) provided by investing activities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(752)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">55,509&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Financing activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Proceeds from issuances of securities</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">43,902</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Costs incurred related to issuances of securities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(1,869)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#8212;&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Proceeds from draws on revolving line of credit from Cibus Global, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2,500&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Payment of taxes related to vested restricted stock units</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(214)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(742)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Proceeds from issuance of notes payable</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">&#8212;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,287&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Repayments of financing lease obligations</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(174)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(242)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Repayments of notes payable</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(741)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(760)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28.37pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net cash provided by financing activities</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">40,904</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">2,043&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Effect of exchange rate changes on cash and cash equivalents</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(2)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Net (decrease) increase in cash and cash equivalents</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">(3,894)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">28,357&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents &#8211; beginning of period</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">32,699</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3,526&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 11pt;text-align:left;text-indent:-10pt;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Cash and cash equivalents &#8211; end of period</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:114%">28,805</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:114%">31,883&#160;</font></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cbus-20241107.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:6f2d5f58-9b0f-4008-a57c-29f803b86dc3,g:e089b08c-f7f8-44a9-a150-acc3899c9e1d-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cbus="http://www.cibus.com/20241107" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cibus.com/20241107">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cbus-20241107_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cbus-20241107_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.cibus.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cbus-20241107_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:6f2d5f58-9b0f-4008-a57c-29f803b86dc3,g:e089b08c-f7f8-44a9-a150-acc3899c9e1d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_ff4a0b15-c9ae-41c6-acff-6adea69264c3_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_5ca14e26-d837-4623-962f-43e18b9451a4_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_763977ea-595e-421f-a918-fb266d4740c8_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2ce907d9-c305-41ee-9f3a-ebc3f96b08b2_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_6acf574a-e635-4a04-88e7-8bc475223939_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_da06b6de-e89e-4a68-93c2-8f85b33c17f6_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_3ba94431-596b-450f-8f71-6525374da1a6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_81cf8b4d-dd5a-4872-8f72-2bbcd93e3104_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_3f71da64-d8b1-430c-8e16-96119e10fe8a_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_787df162-aafb-4a36-9073-124771b962ba_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_2ba28429-27ba-42d8-b2ed-9321347a7abc_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_1472f879-5c20-43b4-93c3-574da95bd91d_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_186972d3-f9d5-47e3-ae5b-9be24ac8576b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_45bf6b9f-fba6-43f9-a7d7-a1288f2f46ef_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_fea1bed8-8cf0-4484-aee2-9d34cbb8f34e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_06e6dd81-5e12-45a8-a939-eb01f5ef3f18_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_7d4242c1-9da8-485e-8048-09964193cfaa_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_f0b50c4a-67a7-4438-959e-cae881993c06_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_f137eaaf-6d36-4524-977d-53262c79dc61_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_6af18a20-6343-43ce-8859-f8bed794bd16_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_889b5a00-807b-45ec-a4b7-6d5b3926058e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_a39093c0-9fda-4bef-aaef-2e95d6219177_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cbus-20241107_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:6f2d5f58-9b0f-4008-a57c-29f803b86dc3,g:e089b08c-f7f8-44a9-a150-acc3899c9e1d-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cibus.com/role/Cover" xlink:type="simple" xlink:href="cbus-20241107.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.cibus.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d751f364-4193-4df2-8e38-0b1fc01cb035" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_DocumentType_d751f364-4193-4df2-8e38-0b1fc01cb035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_4608ff4e-ed30-42d1-9365-b3d8756cea72" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_DocumentPeriodEndDate_4608ff4e-ed30-42d1-9365-b3d8756cea72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_3fb3b56c-449f-48c2-b246-d08cfd9c0983" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_EntityRegistrantName_3fb3b56c-449f-48c2-b246-d08cfd9c0983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_53fd9b45-675a-4dcf-8537-007eb899e856" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_EntityIncorporationStateCountryCode_53fd9b45-675a-4dcf-8537-007eb899e856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b6be0813-dc70-456f-aec4-9371bdc8777b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_EntityFileNumber_b6be0813-dc70-456f-aec4-9371bdc8777b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_44a017a9-fe14-4405-ad1b-d3fc95d583c7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_EntityTaxIdentificationNumber_44a017a9-fe14-4405-ad1b-d3fc95d583c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_bbb599e0-7644-4ae5-9d6e-5d45cfa1071c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_EntityAddressAddressLine1_bbb599e0-7644-4ae5-9d6e-5d45cfa1071c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_3d6e45bd-a42e-456a-b427-8de32897706e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_EntityAddressCityOrTown_3d6e45bd-a42e-456a-b427-8de32897706e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f7964b3f-25c2-4371-895a-d4cdd9a2bb90" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_EntityAddressStateOrProvince_f7964b3f-25c2-4371-895a-d4cdd9a2bb90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_94672370-87c2-40f5-a5d8-2f7f5ce6f2eb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_EntityAddressPostalZipCode_94672370-87c2-40f5-a5d8-2f7f5ce6f2eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_4e3ee61b-cf5b-490d-95b2-a40d0e26f9d0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_CityAreaCode_4e3ee61b-cf5b-490d-95b2-a40d0e26f9d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_22a26403-f0a9-4522-ac85-ca6e048baccb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_LocalPhoneNumber_22a26403-f0a9-4522-ac85-ca6e048baccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_028dcbe8-44ad-4e65-92f1-7f050d809ff7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_WrittenCommunications_028dcbe8-44ad-4e65-92f1-7f050d809ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_b1e5f237-ba1b-449d-99cb-311cf3d02f10" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_SolicitingMaterial_b1e5f237-ba1b-449d-99cb-311cf3d02f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_9da6097e-49de-4404-b905-90aca16526ee" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_PreCommencementTenderOffer_9da6097e-49de-4404-b905-90aca16526ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_6254b701-9a21-48db-9284-346865d4992c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_6254b701-9a21-48db-9284-346865d4992c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_8cc47105-6c85-4ceb-9afd-fe5694bca94b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_Security12bTitle_8cc47105-6c85-4ceb-9afd-fe5694bca94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_49babee1-242e-47d2-b604-61ae29a168e6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_TradingSymbol_49babee1-242e-47d2-b604-61ae29a168e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_3cdc50aa-c601-4fb7-ad63-148a10fd0101" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_SecurityExchangeName_3cdc50aa-c601-4fb7-ad63-148a10fd0101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_c8d19c68-6299-4962-8769-2078c889f6d8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_EntityEmergingGrowthCompany_c8d19c68-6299-4962-8769-2078c889f6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_77738c62-10f5-4749-87b9-d53a8e1c860f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_EntityCentralIndexKey_77738c62-10f5-4749-87b9-d53a8e1c860f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_71ec5a8a-ac91-4bf8-8da3-e2977bdae0f4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b412736e-63ae-4ca5-9328-316ec2dc6f8c" xlink:to="loc_dei_AmendmentFlag_71ec5a8a-ac91-4bf8-8da3-e2977bdae0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>cibus_logoxrgba.jpg
<TEXT>
begin 644 cibus_logoxrgba.jpg
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M  (1 0,1 ?_$ /(  0 # 0$! 0             %!@<$ P(! 0$! 0$! 0$
M            !00# @$&$  ! @0% P0" @$% 0     # 0( $ 0%(#! $3$R
M$P8A$C0U4!1P,Q9@(B,5)201  $" 00-"@4# P,#!0    $" P @$2$Q,$!!
M47&QP1(B,E)R!&&!D:'1X8(3(S,00F*2LE"B%'#Q4V#P--)#8W.#DZ,D$@ "
M  0' 0$            1(4!08'  $" P@) !,: 3 0 ! @()! ,! 0$
M  $1 #$@(3! \$%187&AL1"!D<%0T>'Q<&#_V@ , P$  A$#$0   =4
M             'SY!8<41DQ^?GSW=^]BH4>CKT
M                                                   K,R9 3\
M]??JZ6K79V[
M                       "@P('AS\ >_3WU=>OCX\7FY<_?OT
M
M  "DQ(G!GX 3V_?9:5&A085EITIK;M
M                                          Y./&H2)')QY='3I<[5
MGJZ]:O+E\_/G<+%@
M                            #S\^?3UZ A<.*O3Y][O70
M
M   (G'DJ\R7?K]\
M                         "*R9(W-F[>_>7UZ_OUZ $%@P0F+%>+EP
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MTY^WG[X^GCK\>_OY]^_BX8=H  $1WXYK5F1'?B     /OY]UN)7FN'<
M "!P8*Q+F"8V;+;7K<O'C1(4.^W[W1TZ      "-Z\L9O10   /3Y]T271N&
M':        !DMJ1 Z<X&O1+$UG[@   "G[L6;U9H%UP;M#ET0      !7=6;
M+[$OQ^^0   +%ETZE'J^GSZ  ,UK3+W-WT.E/T.72S2M,TZ13RZQ+U:-6  %
M3VX\WJS?/[\      &KQJUARZ0      (?'CJ4B2/WZOU^_"XL4-BQWF[<
M     C>O+&;T4    ?IIDBI:\>L        9+:D0.G.!KT2Q-9^X    I^[%
MF]6:!=<&[0Y=$      ")[<<BN1_+[\     M>/7ILBH  ,QKR]#ET<\J3OQ
M\FL_>ZX-V36I&LQ:X %.W8LYJS?P $CRZ6K'KF\_?NY]/OXY/?F'[\*SKS06
MG/\ @-7C5K#ET@      1&/'49$D"V5JT#@P2>K39*5(      "-Z\L9O10.
MOQ[MV+7\'!UYU[3G\?7D#H\^MG@VNGQ[        R6U(@=.<#7HEB:S]P
M!3]V+-ZLT"ZX-VARZ(      &2VY$#HS@?3[<L&RT8]?7X]<73Q4-V.J;,@
MU6-6L>72 !4-V,0>CAH\JEFE:7;<6R#T<+]-H "NZLV5V9/R ='GUH4NC;<6
MO]?0  (GMQSZI.KVG/J\:M8<ND      "(QXZC(D@2^S7$8\EXN6^WOW
M   C>O+&;T4"7X]MAA60.;WXRVQ*@M' "_S:%YG;P       ,EM2('3G UZ)
M8FL_<    4_=BS>K- NN#=H<NB      (_KSQ>]$ _34(]6SY-0 % ISJ-0P
M]/GU?IE"X8=GZ^@ ?+YF=>9,\.T]FT0_?C6]6739-3V\^@.3WXQN]%YO7D"0
MY=-8C5I#EU     IV[%)\NL]FT       1&/'49$D#]^NCITOEZ\       (
MWKRQF]% E^/;885D </3GB]^+\O@F>'?7X=@       #);4B!TYP->B6)K/W
M    %/W8LWJS0+K@W:'+H@     "L:\N76)0$UP[Z]#L  #\?*+1PW/!LZ//
ML   "!TYXOMRD.72PY='Z^@#-*TRI;<8'7X]Z_#L=W/H             !$8
M\=1D20!.[]UHJ5       !&]>6,WHH$OQ[;#"L@ 8[=C1/;B/7Y]W/\ .W@
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M>[6[8       $;UY8S>B@2_'ML,*R.?UYJVS)G].?X>O(]OGK9(-GNY]
M    ,EM2('3G UZ)8FL_<    4_=BS>K- NN#=H<NB      !\OF6V95;U9@
M !-Y^]RP[;3BU?3Z       !#=^&07(X$SP[:_#L@              "(QXZ
MC(D@2VO5;[%@       "-Z\L9O10/M]Z?'KS^_/#UY_ #]-1CU;-DU
M  #);4B!TYP->B6)K/W    %/W8LWJS0+K@W:'+H@      #Y^_,]ISJ9OQ?
M@  )#GTT*71LV34       *YJS959D@63+IU2-6               $1CQU&
M1) F=NRV5JP       $;UY8S>B@    2_'MH<NC/9M        &2VI$#IS@:
M]$L36?N    *?NQ9O5F@77!NT.71        $+WX4.E@KVK-^   M^'9H\JE
M]/H      KFK-E5F2!9,NG5(U8               1&/'49$D":V[;76J@
M     1O7EC-Z*     /HTB33MV+8       ,EM2('3G UZ)8FL_<    4_=B
MS>K- NN#=H<NB         (WKRIN_%4MN3P]>0 +9BUZ9)J      "$T<,BM
MQP)GAVU^'9               $1CQU&1) FMNVUUJH       $;UY8S>B@=W
M/I>IVX?/UR^_$/WXU_3G\_OP#[?==AV)CAV       R6U(@=.<#7HEB:S]P
M  !3]V+-ZLT"ZX-VARZ(          \?7FF;\5&HX?'[Y &IQZMER:@
M.3WXQ+]!# ]?GW<?SUWZ^?0              (?%CJ4F2!-;=MKK50
M (WKRQF]% E^/;885D #BZ<\ML2H;OQ L&;1K$6N      !DMJ1 Z<X&O1+$
MUG[@   "G[L6;U9H%UP;M#ET0          !&]>63VI/#TY@3N?OK<2P
M  ,6OQ.#IS U:-6L672              !"XL54DR@)K;MM=:J       !&]
M>6,WHH$OQ[;#"L@ #C]^,9OQ?'[Y'Z;9^?N=?CV      ,EM2('3G UV)8F\
M_<    4S?BSJI- NN#=H<NB           ! :<^36I 'T^[C^=N>OST
M!G-6;3=V("QY=.JQJP              $+BQ523* FMNVUUJH       $;UY
M8S>B@2_'ML,*R  !E]B55]>4#5XU:PY=(      RFS)KNK,!J4>K9LFH
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M6   /Q\Q']##YO7D#;OS]SJ\>P     !P].>.78WAZ\@=OCWJD:M+\.P
M\OOG-ZTVV8M=ARZ0      (C'CJ,B2!-;=MKK50       (WKRQF]% E^/;8
M85D  0&G/D]J1^ _3;?S]SJ\>P     !Q^_&*_H(GR^ :C(JV?'J   % ISZ
M-0P =_/IM,"V      (SMRQJ[% ^GW:(%KNY]  !6M>7++$H#NY]-J@6P
M   !6=>7+K$K\ /3Y]O,[?=<&WV\^@  *SKRY[4G1_3GJ\:M8<ND      ".
MS9J7%C 36W;:ZU4       "-Z\L9O10)?CVV&%9 'E]\U/;DSZG/\?7D"Q9=
M.K1JP       S2M,J6W&![?/NFR*EER:@ !1Z&"@4Y_X :-+I7+!M
MQZ[&B.W$"<S]]6C5O;SZ $;UY9+;D<?OP!=Y^[09E$       "G;L6<U9OX
M#W\^K)DTSF?OW<^GT<_KS$]N59V98SKR U>-6L.72      !Y^/&?P('Y\":
MV[;76J@       1O7EC-Z*![?/4QG[#\^_.?UYC>O/X^_ !Z?/NO0[$MQ[
M     #E]^,=NQN/WX _2?S:+-DU2'+I\D7VXU7;EB>W$ 3>?OKD2O^OH
M  %8UY<NL2@!W\^EPP[);AV^?OR"T<*?NQ^/KR!T>?6RP;77X]@       "K
M[,F:UIGC]^      #5XU:PY=(       I<2+'9\XFMNRUUJP       $;UY8
MS>B@    #Z?=,D4[5CU@       "&[\,HM2>?UY     $ERZZW$K]?CV
M   !E]>55]F4    #Z-/CU;/DU         ".Z\LXJS:_IS@    #L\>]8BU
MY3CU       $3DR5"/($GJTW*S9        C>O+&;T4    #M\>])DT[%ET@
M        "*[<<OL2XSKR    %AS:-.D5.GQ[        'G]^9A7E5K7F
M]?GW2I-.TX]8          $#IST_=CK>K-X^O(  ^GV<S=[9BUVK'K]/GT
M      5"/(B<F3[]?;U=N]'3H       (WKRQV[&  'T>OGUV>/<GQZV#-HM
M.+5Z_/0          ^/ORE[\5-WXN#IS  $QP[7:?NM6/6          *CMQ
MT:C@CNO, #[^?;-DTWZ;0D>74            ?+Y%=^4;UY<WOS\G1Y^]_+I
M+\>WMY]          ?'GS594J'QY/7WZE]>RTU:@
M     $7VXQ/;ES>_/Z=G/W,<.W=SZ            "*[<8GMRY_?GZ^._GTF
ML_?H\^@                            (S+EC,V;T]>K%1H@
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M.0RD&M-<*A3?E2VNWEA_CE L+XQ3PGC--#/'K<V T-&'5FM=O-#_ !N@6/\
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MYA\5%I/>'\1(8P'&;&UOY#(>W1CL\VTL#+DD-).JG2/-+*32#01"L]<W#SZ
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M )C^%,Y.>U#V+4RA;<RQSO.]6R<;;%I,_P!U#3%NPCO-/(W%>'W@@/@O+Z_
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MDDDEVT>DDDDDDDB__P#_ /\ \DDDDDDDDDW_ +))))(_^)))))))) /_ /\
M_P#I))(,UFI))&O_ /\ _P#_ /\ ,DDDDDDD&UD4DDDDDDD7_P#_ /\ [TDD
MDDDDDDF_]DDDDD?_ !)))))))&?_ /\ _P#^)))!@^/)).__ -FR[Y_F2222
M222';;62222222+_ ..&_P"C))))))))-_[))))(_P#B2222222#_P NHO\
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M !))))))).?_ /\ 0\DDDDDDDD?_ ')))))))))))))))(=LY)))))))(O\
M@E_^J222222223?^R2222/\ XDDDDDDDD+__ /\ U22222222;_F22222222
M22222220[:R22222221?_P#_ /\ \622222222;_ -DDDDD?_$DDDDDDDDG3
M_P#_ -.2222223?^R222222222222222';:22222222+_P#_ /\ _P#.DDDD
MDDDDW_LDDDDC_P"))))))))))%=__P#R222222#_ -DDDDDDDDDDDDDDDD.V
MTDDDDDDDD7_3<-7_ !))))))))O_ &22221_\222222222226C_\R222221?
M^F222222222222222+;:22222222+_B22%_^R2222223?^R2222/_B222222
M222221K_ -DDDDDDD7_LDDDDDDDDDDDDDDDNVTDDDDDDDD7_ !)))A_]))))
M)))O^)))))%_Y))))))))))))%_QY))))))/^I)))))))))))))))=MI))))
M)))(O^)))(?_ &2222221?\ \DDDDF_^DDDDDDDDBDDDD/\ ]))))))(_P#^
M222222222222222[;222222221?\2223_P#LDDDDDD@_ZDDDDDW_ /))))))
M%6I))))/_9))))))%_[Y))))))Y)))))))=MI)))))))(O\ B222;_V22222
M21_^R2223[_B222222/_ -DDDG/_ +))))))(M_R)))))'3)))))))#MM)))
M)))))%_Q))(G_;)))))))I_Q)))(/_!))))))!_XI))+_P#22222222*_P#>
MLDD@QYDDDDDDDGVVDDDDDDDDB_XDD_W_ %))))))))/^3)) W_Q)))))))!_
M[9)/?_Y)))))))([_P#[M%X?\R2222221G;222222221?^;5[_\ 7DDDDDDD
MD)_[L&X__P Y))))))(O_P 57;_I222222222$__ /\ _P#_ /YDDDDDDDD6
MQDDDDDDDDB__ /\ _P#_  I)))))))).O_\ _P#_ /XI))))))))_P#_ /\
M_P#G2222222222,__P#_ /\ _P!DDDDDDDDDVLDDDDDDDD7_ /\ _P#_ #9)
M))))))))*/\ _P#_ /R9))))))))(_\ _P#_ /;)))))))))))*M_P#_ ,VD
MDDDDDDDDFQDDDDDDDDG_ /\ \X >222222222202?_\ _P")))))))))) O_
M /\ 3,DDDDDDDDDDDDC#&?LDDDDDDDDDD[U4DDDDDDDDDDDDDDDDDDDDDDDD
MDD/$5DDDDDDDDDDDDD^7&DDDDDDDDDDDDDDDDDDDDDDDDDDDDDA-DDDDDDDD
MDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDG_V@ ( 0$# 3\0
M_"NG *C !=6B"Y15)\A]%33E#A[QY5+ 9G,#X"5N\=1U,L_2FZ5K)7=]EO\
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M46=?JB/A@9L1[[*_"B@%MUG6#[U+9_'I(783*YP"S[Y1"V)"2-W)]L#RC/\
M,=.C("Y\,C$2WV&?!*:N,'#Q9W.B!QI%(0F2-QQY9"SA=TW2X7-W"@\@0 $B
M%QTXL,1G.1@,NISWA"E^7*(VS^/2G_(@H)$3,1IR L$!,^1,^3._YGIT9 Z,
MVR]XY63A(J*T9D9\CS:-CJRVAOED.9EBF!PW];+O;-SU3IF+,FL3$KV6!$(/
M?0N_Y<HC;/X\!@O1$1%D@F[U,,==S-!1T*"B!=T/O*9T)EDATT>0:2VT*ES
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MEG1 %M_2@ EG_B2IP<SWP3\*1\T+*S2*]S4@[^#_ ,2@;?<TUDRX[O1&!^J
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FNXCQXI=D5SU&\7:MW3U:L8/SC><=0-;J3W_BCTA.1E?Y?_7?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45707361061328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 07, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  07,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Cibus, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-1967997<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6455 Nancy Ridge Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">450-0008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CBUS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001705843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M#P0E1EABA(7>+89!_AXOC=60J'_JB X*K7H%5[UW)F,1'WI0GH;K+?=&/_U
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M]P#<7REEWP=NVUK^UV'T'U!+ P04    " !G@6=9GZ ;\+$"  #B#   #0
M 'AL+W-T>6QE<RYX;6S=5VUKVS 0_BM"/V!N8FKBD1BV0&&PC4+S85^56'8$
M>O%DN7/ZZZ>S;"=I=67=A['-H<G=/;J[1W<GF:Y;=Y+\X<BY([V2NMW0HW/-
M^R1I#T>N6/O.-%Q[I#)6,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZF
MTVY#;VA2K"NCSY:4!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,7
M8&F? KP(&K <XRBAC05C$C*$[_VX_!DP::U7A90SP24-AF+=,.>XU7=>&18/
MQA<0&>7=J?$,:\M.B^4M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<
M45XH!:N-9@.'R6,4?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,
M%F)?A+W]K;"D$8_&?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>
M]O[+"8LUF_S(T5CQY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M
M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1.XJR
MY/K%.?7A'=O["_PJOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD<VW
ML,\E=,E[7FY'U=;[021>\%G'!QR>(W?#$T<PGX#%$<"P/!@#S"=X87G^I_VL
MT/T$#..VBB(KU&>%^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/
MAG$##RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+
MV.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0
MIA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " !G@6=9EXJ[
M',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6
M!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV
M)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O
M@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=
MI7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    (
M &>!9UFJQ"(6,P$  "("   /    >&PO=V]R:V)O;VLN>&ULC5'1;L(P#/R5
M*A^P%K0A#5%>0-N0I@V-B??0NM0BB2O'A8VOG]NJ&M)>]I3<V;K<7187XM.!
MZ)1\>1=B;FJ19IZFL:C!VWA'#02=5,3>BD(^IK%AL&6L <2[=)IEL]1;#&:Y
M&+6VG-X"$B@$*2C9$7N$2_R==S Y8\0#.I3OW/1W!R;Q&-#C%<K<9":)-5U>
MB/%*0:S;%4S.Y68R#/; @L4?>M>9_+2'V#-B#Q]6C>1FEJE@A1REW^CUK7H\
M@RX/J!5Z0B? :ROPS-0V&(Z=C*9(;V+T/8SG4.*<_U,C5146L*:B]1!DZ)'!
M=09#K+&))@G60VY6= ;N\N@#FW+()FKJIBF>HPYX4P[V1D\E5!B@?%.9J+SV
M4VPYZ8Y>9WK_,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    " !G@6=9)!Z;
MHJT   #X 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P
M#(6O$N4 -5"I0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=N
MH+;S)$9K!LIDR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFB
MG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6
M<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ 9X%G
M6660>9(9 0  SP,  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O
M$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1
ML.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3K
MU3.T<F^I>.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY8
M4(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"
MJ;$#(&?KT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R
M]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>
M?P%02P$"% ,4    " !G@6=9!T%-8H$   "Q    $               @ $
M    9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( &>!9UF)7+_<[0   "L"
M   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0
M   ( &>!9UF97)PC$ 8  )PG   3              "  <L!  !X;"]T:&5M
M92]T:&5M93$N>&UL4$L! A0#%     @ 9X%G69)[63Q)!   @1   !@
M         ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0
M   ( &>!9UF?H!OPL0(  .(,   -              "  8L,  !X;"]S='EL
M97,N>&UL4$L! A0#%     @ 9X%G69>*NQS     $P(   L
M ( !9P\  %]R96QS+RYR96QS4$L! A0#%     @ 9X%G6:K$(A8S 0  (@(
M  \              ( !4!   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M &>!9UDD'INBK0   /@!   :              "  ; 1  !X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( &>!9UEED'F2&0$  ,\#   3
M              "  942  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )
-  D /@(  -\3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cbus-20241107.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cibus.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="cbus-20241107.htm">cbus-20241107.htm</File>
    <File>cbus-20241107.xsd</File>
    <File>cbus-20241107_lab.xml</File>
    <File>cbus-20241107_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cbus-20241107.htm": {
   "nsprefix": "cbus",
   "nsuri": "http://www.cibus.com/20241107",
   "dts": {
    "inline": {
     "local": [
      "cbus-20241107.htm"
     ]
    },
    "schema": {
     "local": [
      "cbus-20241107.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cbus-20241107_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cbus-20241107_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.cibus.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cbus-20241107.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cbus-20241107.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.cibus.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001628280-24-046265-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-24-046265-xbrl.zip
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M>=IJBFTN' 4SX5Q"Q\A"NI?(G314[J5YUKW4T/Y(7!N$:":HAM%V\48\X.1
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M22S\@)9KZ/CBF*A:,;/9.AX8P.BM=J_DUOH:4KM==T'>)-$G-:MNP:1VF>)
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M[/ZHU^SKS6Y[=5ZKT<6.9$"[-]![O?Y>*'/ R"*]U7U1:<B?S@(^X5[HW'$
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M;2>2>5>.I]U._#D\T0: >_%@<9!"-QCFHZ^_\4#^=38%L1>%[]>;[KM"Z7!
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M%S#"ZXOYRMG_4$3_7TA:_P=02P,$%     @ 9X%G68S9/[)< @  \ 8  !$
M  !C8G5S+3(P,C0Q,3 W+GAS9,U46V_:,!1^YU=X>9YS(5 2!%1:JTJ3V$5=
MJ_5M,LX)6$WLS'8*_?>S32Q(6SJQI^7)^<[WG9O/\>QR5U?H":1B@L^#)(P#
M!)R*@O'U/+B_N\%9<+D8#&8?,'[X=+M$UX*V-7"-KB00#07:,KU!>@/HIY"/
M[(F@[Q71I9 UQ@LGNQ+-LV3KC4;#>#CR-&^5TXMR6(S+<8;S55SB41QGF(PG
M% _S,HO35791T/3C>@IQ9@@9Q>6DS/!H1'),DG&,":5IEN<TAZ1P3G=JJN@&
M:H),:5Q-=VH>;+1NIE&TW6[#;1H*N8Z&<9Q$#U^6/QPUZ+@5XX\]]FXE*\]/
M(VM>$06>3E=MWSEE!@FIJ"-;:Y+$DP 1K:6!-=R8IEQ#2=I*SX.6_VY)Q4H&
MA>EX!;:G/<*161.Y!OV5U* :0N%O$1<#A&P76-T(J1%_4]<OC'&E":>FL'WK
MEH(2[2;BI,3^8:_#%L+)$*=)N%-%$/U##H?FGI>#UYV?@W.F@(9K\105P&P+
MT[?#JU-T>\#VT(]).!?:Z2W284W#>"GV@(%LXE.?_2V4?EY?#6$WLDF>YY&S
MFOES8B*I%!6\3XX:*1J0FH$Z'F#G8".AG =VC+$?GU^-A-!DXBFO O2OP)I-
M!%!F?EV]RT-!WH5^;HP+9>ZA@GV+_N?Z*[(ZMWXC@>K,PJWPSM@1*^;!E3!/
M<( L=G_[^<2"NU![IG?EG150,L[<N,7N2Q ^/-48.=4L>LE]X:554'SC"W=^
M>:6=N*.\(Z2DHFUUONZ0UDE9!_K.=9L5]5=K_W^T?@[8[_1B\ =02P,$%
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M%]K<"\9UIH"HS $1P4EB,VZ0. 6!QZ"2"8_GV_F[08=[^C<0]I?UIP5>&,/
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M?U!+ 0(4 Q0    ( &>!9UGO*[8>J#\  ,($ P 4              "  0
M  !C8G5S+3(P,C0P.3,P>'!R+FAT;5!+ 0(4 Q0    ( &>!9UDD/"0-(@\
M )1G   1              "  =H_  !C8G5S+3(P,C0Q,3 W+FAT;5!+ 0(4
M Q0    ( &>!9UF,V3^R7 (  / &   1              "  2M/  !C8G5S
M+3(P,C0Q,3 W+GAS9%!+ 0(4 Q0    ( &>!9UG%_Y9[! H  'U4   5
M          "  ;91  !C8G5S+3(P,C0Q,3 W7VQA8BYX;6Q02P$"% ,4
M" !G@6=91Z*0,:L&  #8,   %0              @ 'M6P  8V)U<RTR,#(T
B,3$P-U]P<F4N>&UL4$L%!@     %  4 1@$  ,MB      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>cbus-20241107_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cbus-20241107.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001705843</identifier>
        </entity>
        <period>
            <startDate>2024-11-07</startDate>
            <endDate>2024-11-07</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0001705843</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2024-11-07</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Cibus, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-38161</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">27-1967997</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">6455 Nancy Ridge Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">450-0008</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Class A Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">CBUS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
